drugset / Trial / NCT05818956
A Study of TAK-227 in Healthy Adults
RandomizedCrossoverOpen-labelOther
Summary
The main aim of this study is to test the effects of food consumption with sponsor compound TAK-227 in healthy participants. The study will also measure side effects, and to check how much TAK-227 stays in the blood over time to work out the best dose.
Timeline
- Start
- 2023-05-25
- Primary completion
- 2023-06-19
- Completion
- 2023-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZED1227 | Small molecule | 50 mg | Oral |
Indications
No indication recorded.